Compared with normal group, CRS in model group decreased GluR1 and p-GluR1 protein expression in CA3, GluR2 in CA3 and DG, p-GluR2 in CA1, CA3, and DG, and GluR3 in CA1 (P<0.05 or P<0.01), which were reversed by FWP treatment (P<0.05 or P<0.01, except for GluR2 in DG). The gene discussed is GRIA2; the disease is congenital rubella syndrome.